XLRN Historical Earnings image   This XLRN historical earnings page last updated 11/8/2021
XLRN Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202111/4/20210.03B
Q2 20218/5/20210.03B
Q1 20215/6/20210.02B
Q4 20202/25/20210.03B
Q3 202011/5/20200.02B
Q2 20208/6/20200.04B
Q1 20205/11/20200.00B
Q4 20192/27/20200.04B
Q3 201911/6/20190.00B
Q2 20198/5/20190.03B
Q1 20195/9/20190.00B
Q4 20182/27/20193.82M
Q3 201810/30/20183.26M
Q2 20188/2/20183.69M
Q1 20185/8/20183.23M
Q4 20172/27/20183.71M
Q3 201711/7/20173.01M
Q2 20178/3/20173.06M
Q1 20175/8/20173.71M
Q4 20163/1/20173.37M
Q3 201611/3/20163.00M
Q2 20168/4/20163.19M
Q1 20165/5/201618.20M
Q4 20152/25/20163.80M
Q3 201511/4/20154.16M
Q2 20158/6/20155.72M
Q1 20155/7/20154.42M
Q4 20143/2/20153.74M
Q3 201411/7/20143.51M
Q2 20148/12/20144.08M
Q1 20145/15/20143.31M
Q4 20132/26/201411.50M
Q3 201311/6/20130.00B
XLRN Historical Earnings EPS
Data adjusted for XLRN split history

PeriodHistorical Earnings DateGAAP
Q3 202111/4/2021-1.160
Q2 20218/5/2021-1.050
Q1 20215/6/2021-1.050
Q4 20202/25/2021-0.950
Q3 202011/5/2020-0.660
Q2 20208/6/2020-0.340
Q1 20205/11/2020-0.950
Q4 20192/27/2020-0.440
Q3 201911/6/2019-0.860
Q2 20198/5/2019-0.340
Q1 20195/9/2019-0.740
Q4 20182/27/2019-0.75
Q3 201810/30/2018-0.63
Q2 20188/2/2018-0.63
Q1 20185/8/2018-0.58
Q4 20172/27/2018-0.62
Q3 201711/7/2017-0.65
Q2 20178/3/2017-0.77
Q1 20175/8/2017-0.66
Q4 20163/1/2017-0.51
Q3 201611/3/2016-0.55
Q2 20168/4/2016-0.59
Q1 20165/5/20160.13
Q4 20152/25/2016-0.81
Q3 201511/4/2015-0.36
Q2 20158/6/2015-0.32
Q1 20155/7/2015-0.45
Q4 20143/2/2015-0.55
Q3 201411/7/2014-0.25
Q2 20148/12/2014-0.52
Q1 20145/15/2014-0.3
Q4 20132/26/2014-0.64
Q3 201311/6/2013-5.62
Quotes delayed 20 minutes

Email EnvelopeFree XLRN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Acceleron Pharma (XLRN) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

XNCR Past Earnings
XOMA Past Earnings
XRAY Past Earnings
YMAB Past Earnings
YMTX Past Earnings
YTEN Past Earnings
ZBH Past Earnings
ZGNX Past Earnings
ZIOP Past Earnings
ZNTL Past Earnings
What was the record high XLRN historical earnings result?
In terms of earnings or revenue, what is the best XLRN historical earnings result that Acceleron Pharma has ever posted, and when?

✔️Accepted answer: Within our data set, the highest XLRN historical earnings result was set in Q1 2016, when Acceleron Pharma posted results of 0.13/share. The most successful revenue quarter within our data set was Q2 2020 when Acceleron Pharma reported revenue of 0.04B.

What was the lowest Acceleron Pharma historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest XLRN has reported, and when?

✔️Accepted answer: Within our data set, the lowest XLRN historical earnings result was set in Q3 2013, when Acceleron Pharma posted results of -5.62/share. The smallest revenue quarter within our data set was Q1 2019 when Acceleron Pharma reported revenue of 0.00B.

On this page we presented the XLRN historical earnings date information for Acceleron Pharma. Reviewing that XLRN Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2016, when XLRN posted gaap of 0.13/share. Meanwhile the lowest XLRN historical earnings result was in Q3 2013, when XLRN posted gaap of -5.62/share. Moving to Acceleron Pharmas historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2020 when XLRN reported 0.04B in revenue, while the smallest revenue quarter was Q1 2019 when XLRN reported 0.00B in revenue.

For self directed investors doing their due diligence on XLRN or any other given stock, their research can benefit from looking into all of the Acceleron Pharma historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Acceleron Pharma historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for XLRN. Thanks for visiting, and the next time you need to research XLRN historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.
 

XLRN Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2021, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.